Search results for: Kalipso Chalkidou
Filter search results
New publication: Using Patient Reported Outcomes to Improve Health Care
21 December 2015
…the book, Professor Kalipso Chalkidou (NICE international) stresses the importance and relevance of PROs: “They [PROs] can empower patients in making choices about their treatment…They can boost policy makers’ efforts…
As UN General Assembly Highlights Tuberculosis Fight, Will BRICS Lead on the R&D Agenda?
26 September 2018
…the fight against TB will likely depend on their leadership. Rachel Silverman and Kalipso Chalkidou are at The Center for Global Development (CGD). This blog post has also been published…
Unpacking the Black Box of Payer Policy: A Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation
21 February 2020
…Note published by the Center for Global Development available here, authors Kalipso Chalkidou, Adrian Towse and Rachel Silverman argue that neither (i) current limited private sector markets in MLICs, nor (ii) donor push funding is delivering. The current model…
Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB
24 March 2022
…TB, but, as a 2020 paper from OHE and Center for Global Development (CGD) authors highlighted ( Chalkidou et al., 2020), the rate of decline is slow, and the 2035…
Would Waiving COVID-19 Vaccines Patents Save Lives?
18 May 2021
…Mestre‐Ferrandiz, J., 2015. Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context. Health Economics, 24(3), pp.294–301. https://doi.org/10.1002/hec.3021. Chalkidou, K., Claxton, K., Silverman, R. and Yadav, P., 2020. Value-based…
How Should the World Pay for a COVID-19 Vaccine?
26 May 2020, 12:00am
…better understanding of which policies work and which do not – knowledge which can produce lasting benefit in other areas of health need. Related Research: Silverman R, Krubiner C, Chalkidou…
The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?
22 May 2020
…to develop better technologies that deliver more health and economic gain. Chalkidou, K., Towse, A., Silverman, R., Garau, M., & Ramakrishnan, G. (2020). Market-driven, value-based, advance commitment (MVAC): accelerating the…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…Missing a Central Role for HTA and Value Assessment. OHE Research Paper, London: Office of Health Economics. Berdud, M., Chalkidou, K., Dean, E., Ferraro, J., Garrison, L., Nemzoff, C. and…
The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback
5 March 2019
…Development. This blog post has also been published on the Center for Global Development website. Chalkidou, K., Garau, M., Nemzoff,C., Rodes-Sanchez, M., Silverman, R., and Towse A. (2019). Blueprint for…